Advertisement
Immune activation alters cellular and humoral responses to yellow fever 17D vaccine
Enoch Muyanja,1 Aloysius Ssemaganda,1 Pearline Ngauv,2 Rafael Cubas,2 Helene Perrin,2 Divya Srinivasan,2 Glenda Canderan,2 Benton Lawson,3 Jakub Kopycinski,4 Amanda S. Graham,5 Dawne K. Rowe,5 Michaela J. Smith,5 Denis Gaucher,6 Sharon Isern,5 Scott Michael,5 Guido Silvestri,3 Thomas H. Vanderford,3 Erika Castro,7 Giuseppe Pantaleo,7,8 Joel Singer,9 Jill Gillmour,4 Noah Kiwanuka,1,10 Annet Nanvubya,1 Claudia Schmidt,11 Josephine Birungi,1 Josephine Cox,4 Elias K. Haddad,2 Pontiano Kaleebu,1,12 Patricia Fast,11 Rafick-Pierre Sekaly,2 and Lydie Trautmann2
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Muyanja, E. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Ssemaganda, A. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Ngauv, P. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Cubas, R. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Perrin, H. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Srinivasan, D. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Canderan, G. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Lawson, B. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Kopycinski, J. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Graham, A. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Rowe, D. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Smith, M. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Gaucher, D. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Isern, S. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Michael, S. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Silvestri, G. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Vanderford, T. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Castro, E. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Pantaleo, G. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Singer, J. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Gillmour, J. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Kiwanuka, N. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Nanvubya, A. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Schmidt, C. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Birungi, J. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Cox, J. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Haddad, E. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Kaleebu, P. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Fast, P. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Sekaly, R. in: PubMed | Google Scholar
1Uganda Virus Research Institute–International AIDS Vaccine Initiative (UVRI-IAVI) HIV Vaccine Program, Uganda Virus Research Institute (UVRI), Entebbe, Uganda. 2Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, USA. 3Center for AIDS Research Virology Core, Emory Vaccine Center, Atlanta, Georgia, USA. 4International AIDS Vaccine Initiative Human Immunology Laboratory, Imperial College, London, United Kingdom. 5Department of Biological Sciences, Florida Gulf Coast University, Fort Myers, Florida, USA. 6Centre de Recherche de l’Universite de Montreal, Montreal, Quebec, Canada. 7Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 8Swiss Vaccine Research Institute, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. 9Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network, Vancouver, British Columbia, Canada. 10Makerere University School of Public Health, Entebbe, Uganda. 11International AIDS Vaccine Initiative, New York, New York, USA. 12MRC/UVRI Uganda Research Unit on AIDS, Entebbe, Uganda.
Find articles by Trautmann, L. in: PubMed | Google Scholar
Published October 1, 2014 - More info
J Clin Invest. 2014;124(10):1–1. https://doi.org/10.1172/JCI77956.
Copyright © 2014, American Society for Clinical Investigation
Original citation: J Clin Invest. 2014;124(7):3147–3158. doi:10.1172/JCI75429.
Citation for this corrigendum: J Clin Invest. 2014;124(10):4669. doi:10.1172/JCI77956.
Denis Gaucher was omitted from the author list. In addition, affiliations were omitted for Noah Kiwanuka and Pontiano Kaleebu, Claudia Schmidt’s affiliation was incorrect, and affiliation numbers 4 and 7 were incomplete. The correct author and affiliation lists are above.
The authors regret the error.
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)